Episode Details
Back to EpisodesNavigating HER2+ Early Breast Cancer: When to Use Neoadjuvant Therapies, Addressing Residual Disease, and Potential Treatment Toxicities
Episode 476
Published 1 year, 6 months ago
Description
Drs. Traina and Isaacs share how they determine which patients are appropriate for neoadjuvant therapies and how to address residual disease, as well as potential treatment toxicities.